 Guardion Health Sciences, Inc. Guardion or the Company GHSI, today announced the closing of its previously announced underwritten public offering of 24,500,000 shares of its common stock or pre-funded warrants to purchase common stock in lieu thereof and Series B warrants to purchase up to 24,500,000 shares of the Companys common stock. Each share of common stock or pre-funded warrant was sold together with one Series B warrant to purchase one share of common stock at a combined price to the public of 0.342 per share and warrant. 